Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Drug Discovery Targeted to the Alzheimer's APP mRNA 5'-Untranslated Region: The Action of Paroxetine and Dimercaptopropanol

1 Jan 2003

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Drug Transport and Resistance Mechanisms
Share to Genetics and Neurodevelopmental Disorders

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 14501007
DOI: 10.1385/jmn:20:3:267

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Drug Discovery Targeted to the Alzheimer's APP mRNA 5'-Untranslated Region: The Action of Paroxetine and DimercaptopropanolPMID 14501007Read ↗

Alzheimer’s and ABC transporters — new opportunities for diagnostics and treatmentSemantic proximity Read ↗

Therapeutic potential of APP antisense oligonucleotides for Alzheimer’s disease and down syndrome-related Alzheimer’s diseaseSemantic proximity Read ↗

Psychotropic drug effects on gene transcriptomics relevant to Alzheimer disease.Semantic proximity Read ↗

Strategies to gain novel Alzheimer’s disease diagnostics and therapeutics using modulators of ABCA transportersSemantic proximity Read ↗

Apolipoprotein E as a Target for Developing New Therapeutics for Alzheimer's Disease Based on Studies From Protein, RNA, and Regulatory Region of the GeneSemantic proximity Read ↗

Identifying Novel Candidates for Re-Purposing as Potential Therapeutic Agents for Alzheimer’s diseaseSemantic proximity Read ↗

What to Test in Parkinson Disease Prevention Trials? Repurposed, Low-Risk, and Gene-Targeted Drugs.Semantic proximity Read ↗

The P2X7 receptor: a new therapeutic target in Alzheimer’s diseaseSemantic proximity Read ↗

Inactive variants of death receptor p75NTR reduce Alzheimer’s neuropathology by interfering with APP internalizationSemantic proximity Read ↗

Design of an orally bioavailable small molecule that modulates the microtubule-associated protein tau’s pre-mRNA splicingSemantic proximity Read ↗

Targeting Alzheimer's disease genes with RNA interference: an efficient strategy for silencing mutant alleles.Semantic proximity Read ↗

Precision Medicine for Parkinson's Disease: Ambroxol for Glucocerebrosidase-Associated Parkinson's Disease, First Trial Completed.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.